{"nct_id":"NCT00778830","title":"Study Evaluating the Safety and Efficacy of FOLFIRI Plus Cetuximab or FOLFOX Plus Cetuximab as First-line Therapy in Subjects With KRAS Wild-type Metastatic Colorectal Cancer (APEC-Study)","status":"COMPLETED","status_verified_date":"2015-04","start_date":"2009-02","start_date_type":null,"primary_completion_date":"2014-04","primary_completion_date_type":"ACTUAL","completion_date":"2014-04","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["MRK"]}